Recruiting
Phase 2

Botulinum Toxin

Sponsor:

Meshalkin Research Institute of Pathology of Circulation

Code:

NCT02008448

Conditions

Persistent Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Pulmonary vein isolation

Linear Lesion Ablation

BT injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Meshalkin Research Institute of Pathology of Circulation on 2015-09-23.